Bone metastases: pathophysiology and management policy.
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The pathophysiology and options for management of bone metastases as well as criteria for determining response to therapy are reviewed. Bone metastases are frequently one of the first signs of disseminated disease in cancer patients. In the majority of patients, the primary tumor is in the breast, prostate, or lungs. Although almost all patients will die of their disease, a proportion of the patients will survive for several years. Treatment is primarily palliative: the intention is to relieve pain, prevent fractures, maintain activity and mobility, and, if possible, to prolong survival. Therapeutic options include local treatment with radiotherapy and/or surgery, and systemic treatment using chemotherapy, endocrine therapy, radioisotopes, agents such as diphosphonates, which inhibit resorption of bone, as well as analgesic and antiinflammatory drugs. The mechanisms by which pain is relieved by several of these therapies remain unclear but actions beyond a simple tumoricidal effect appear to be important. There have been few randomized trials comparing the therapeutic options, and the criteria for assessing response to therapy have, in general, been poorly defined. There is a need for rigorous clinical investigations that assess the efficacy of the various therapeutic possibilities by using well-defined and validated criteria of response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A., & Goodman, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908173210702 · Cited by 1,464
Foley, K. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507113130205 · Cited by 974
Biological Diversity in Metastatic Neoplasms: Origins and Implications
Fidler, I. J., & Hart, I. R. (1982) · Science · doi:10.1126/science.7112116 · Cited by 928
Who should measure quality of life, the doctor or the patient?
Slevin, M., Plant, H., Lynch, D., Drinkwater, J., & Gregory, W. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.20 · Cited by 904
Tumor heterogeneity and the biology of cancer invasion and metastasis.
Fidler, I. J. (1978) · PubMed · Cited by 818
Tong, D., Gillick, L., & Hendrickson, F. R. (1982) · Cancer · doi:10.1002/1097-0142(19820901)50:5<893::aid-cncr2820500515>3.0.co;2-y · Cited by 790
Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer
Coates, A., Gebski, V., Bishop, J. F., Jeal, P. N., Woods, R. L., Snyder, R., Tattersall, M. H. N., Byrne, M., Harvey, V., Gill, G., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712103172402 · Cited by 537
Clinical use of Prostate Specific Antigen in Patients with Prostate Cancer
Hudson, M. A., Bahnson, R. R., & Catalona, W. J. (1989) · Journal of Urology · doi:10.1016/s0022-5347(17)38972-3 · Cited by 491
Cancer of the Breast: The Past Decade
Henderson, I. C., & Canellos, G. P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020104 · Cited by 467
Tannock, I., Gospodarowicz, M., Meakin, W., Panzarella, T., Stewart, L., & Rider, W. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.5.590 · Cited by 407
Self-citationEVALUATION OF QUALITY OF LIFE IN PATIENTS RECEIVING TREATMENT FOR ADVANCED BREAST CANCER
Priestman, T. J., & Baum, M. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92112-7 · Cited by 399
Quality of Life End Points in Cancer Clinical Trials: Review and Recommendations
Moinpour, C. M., Feigl, P., Metch, B., Hayden, K. A., Meyskens, F. L., & Crowley, J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.7.485 · Cited by 379
Tannock, I. F., Boyd, N. F., DeBoer, G., Erlichman, C., Fine, S., Larocque, G., Mayers, C., Perrault, D., & Sutherland, H. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.9.1377 · Cited by 348
Self-citationMeasuring quality of life in cancer patients.
Donovan, K., Sanson-Fisher, R. W., & Redman, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.7.959 · Cited by 329
Spread of prostatic cancer to bone
Jacobs, S. C. (1983) · Urology · doi:10.1016/0090-4295(83)90147-4 · Cited by 286
The development of a method for assessing the quality of life of cancer patients
Selby, P. J., Chapman, J. A., Etazadi-Amoli, J., Dalley, D., & Boyd, N. F. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.134 · Cited by 277
Breast cancer: metastatic patterns and their prognosis.
Patanaphan, V., Om, S., & Risco, R. (1988) · PubMed · Cited by 260
Cancer of the Breast: The Past Decade
Henderson, I. C., & Canellos, G. P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001103020203 · Cited by 257
Bataille, R., Chappard, D., Marcelli, C., Dessauw, P., Sany, J., Baldet, P., & Alexandre, C. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.12.1909 · Cited by 241
Cole, D. J. (1989) · Clinical Oncology · doi:10.1016/s0936-6555(89)80035-4 · Cited by 228
Quality of life in stage II breast cancer: an instrument for clinical trials.
Levine, M. N., Guyatt, G. H., Gent, M., De Pauw, S., Goodyear, M. D., Hryniuk, W. M., Arnold, A., Findlay, B., Skillings, J. R., & Bramwell, V. H. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.12.1798 · Cited by 223
Assessing quality of life in cancer patients
Maguire, P., & Selby, P. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.301 · Cited by 197
Incidence of Fracture Through Metastases in Long Bones
Fidler, M. (1981) · Acta Orthopaedica Scandinavica · doi:10.3109/17453678108992157 · Cited by 179
Genetic Control of Cancer Metastasis
Fidler, I. J., & Radinsky, R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.3.166 · Cited by 175
Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?
Tannock, I. F. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.7.1013 · Cited by 170
Self-citationTherapy of small cell lung cancer: a perspective on two decades of clinical research.
SEIFTER, E. J., & Ihde, D. C. (1988) · PubMed · Cited by 165
Metastatic breast cancer confined to the skeletal system
Sherry, M. M., Greco, F. A., Johnson, D. H., & Hainsworth, J. D. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90286-x · Cited by 160
Coates, A. S., Dillenbeck, C. F., McNeil, D., Kaye, S. B., Sims, K., Fox, R. M., Woods, R. L., Milton, G. W., Solomon, J., & Tattersall, M. H. N. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90096-2 · Cited by 156
Maxon, H. R., Schroder, L. E., Thomas, S. R., Hertzberg, V., Deutsch, E., Scher, H. I., Samaratunga, R. C., Libson, K., Williams, C. C., & Moulton, J. S. (1990) · Radiology · doi:10.1148/radiology.176.1.1693784 · Cited by 148
Turner, J. H., Claringbold, P. G., Hetherington, E. L. R., Sorby, P. J., & Martindale, A. A. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.12.1926 · Cited by 137
Diagnosis and Management of Breast Cancer.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-782_1 · Cited by 133
Robinson, R. G., Blake, G. M., Preston, D. F., McEwan, A. J. B., Spicer, J. A., Martin, N., Wegst, A. V., & Ackery, D. M. (1989) · Radiographics · doi:10.1148/radiographics.9.2.2467331 · Cited by 131
Strontium-89 therapy for the pain of osseous metastases.
Silberstein, E. B., & Williams, C. C. (1985) · PubMed · Cited by 127
Buchali, K., Correns, H. J., Schuerer, M., Schnorr, D., Lips, H., & Sydow, K. (1988) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00254382 · Cited by 95
Palliative irradiation of bone metastases
Poulsen, H. S., Nielsen, O. S., Klee, M., et al. (1989) · Cancer Treatment Reviews · doi:10.1016/0305-7372(89)90003-0 · Cited by 77
Self-citationThe chemotactic response of tumor cells. A model for cancer metastasis.
Lam, W. C., Delikatny, E. J., Orr, F. W., Wass, J. A. H., Varani, J., & Ward, P. A. (1981) · PubMed · Cited by 71
Bone Metastases and Bone Pain in Breast Cancer
Front, D. (1979) · JAMA · doi:10.1001/jama.1979.03300160027019 · Cited by 69
Manishen, W. J., Sivananthan, K., & Orr, F. W. (1986) · PubMed · Cited by 67
Hoskin, P., Ford, H. T., & Harmer, C. (1989) · Clinical Oncology · doi:10.1016/s0936-6555(89)80037-8 · Cited by 66
Bone metastases in breast cancer, prostate cancer and myeloma.
Paterson, A. H. (1987) · PubMed · Cited by 64
Carcinoma of the Breast Metastatic to the Skeleton
Miller, F., & Whitehill, R. (1984) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198404000-00016 · Cited by 61
Mouridsen, H. T., Rose, C., Engelsman, E., Sylvester, R. J., & Rotmensz, N. (1985) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(85)90128-2 · Cited by 38
Munro, A., Biruls, R., Griffin, A., Thomas, H. C., & Vallis, K. A. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.287 · Cited by 31
Self-citationChemotherapy of skeletal metastases
Cadman, E. C., & Bertino, J. R. (1976) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(76)90097-3 · Cited by 14
Cited by
Microwave Ablation: Principles and Applications
Simon, C. J., Dupuy, D. E., & Mayo-Smith, W. W. (2005) · RadioGraphics · doi:10.1148/rg.25si055501 · Cited by 1,023
Malignant bone pain: pathophysiology and treatment
Mercadante, S. (1997) · Pain · doi:10.1016/s0304-3959(96)03267-8 · Cited by 861
Macedo, F., Ladeira, K., Pinho, F., Saraiva, N., Bonito, N., Pinto, L., & Gonçalves, F. (2017) · Oncology Reviews · doi:10.4081/oncol.2017.321 · Cited by 775
Goetz, M. P., Callstrom, M. R., Charboneau, J. W., Farrell, M. A., Maus, T. P., Welch, T. J., Wong, G. Y., Sloan, J. A., Novotny, P. J., Petersen, I. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.097 · Cited by 608
Molecular mechanisms of cancer pain
Mantyh, P. W., Clohisy, D. R., Koltzenburg, M., & Hunt, S. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc747 · Cited by 477
Metadata
- Authors
- Nielsen, O. S., Munro, A. J., & Tannock, I. F.
- Venue
- Journal of Clinical Oncology
- Published
- 1991-03
- Volume
- 9
- Issue
- 3
- Pages
- 509-524
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1920947400
- Cited by
- 486
- References
- 44
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.